Cite
Therapeutic In Vivo Gene Editing Achieved by a Hypercompact CRISPR‐Cas12f1 System Delivered with All‐in‐One Adeno‐Associated Virus (Adv. Sci. 19/2024).
MLA
Cui, Tongtong, et al. “Therapeutic In Vivo Gene Editing Achieved by a Hypercompact CRISPR‐Cas12f1 System Delivered with All‐in‐One Adeno‐Associated Virus (Adv. Sci. 19/2024).” Advanced Science, vol. 11, no. 19, May 2024, p. 1. EBSCOhost, https://doi.org/10.1002/advs.202470108.
APA
Cui, T., Cai, B., Tian, Y., Liu, X., Liang, C., Gao, Q., Li, B., Ding, Y., Li, R., Zhou, Q., Li, W., & Teng, F. (2024). Therapeutic In Vivo Gene Editing Achieved by a Hypercompact CRISPR‐Cas12f1 System Delivered with All‐in‐One Adeno‐Associated Virus (Adv. Sci. 19/2024). Advanced Science, 11(19), 1. https://doi.org/10.1002/advs.202470108
Chicago
Cui, Tongtong, Bingyu Cai, Yao Tian, Xin Liu, Chen Liang, Qingqin Gao, Bojin Li, et al. 2024. “Therapeutic In Vivo Gene Editing Achieved by a Hypercompact CRISPR‐Cas12f1 System Delivered with All‐in‐One Adeno‐Associated Virus (Adv. Sci. 19/2024).” Advanced Science 11 (19): 1. doi:10.1002/advs.202470108.